Latest Rivaroxaban Stories
Janssen Expands EXPLORER Cardiovascular Research Program to Include New, Multi-Trial, Prospective Research Program Aimed at Generating New Evidence in Treating and Preventing Cancer-Associated Blood
COSTA MESA, Calif., May 18, 2015 /PRNewswire-iReach/ -- California CRO WCCT Global recently completed a study on elderly subjects
Results Add to Findings from Ongoing Five-Year Post-Marketing Safety Program of XARELTO® Use in Clinical Practice NATIONAL HARBOR, Md., May 15, 2015 /PRNewswire/ -- New data from an ongoing
VENTURE-AF, the First Global, Prospective, Randomized Trial of Any Novel Oral Anticoagulant in this Setting, Presented as Late-Breaking Clinical Trial RARITAN, N.J., May 14, 2015 /PRNewswire/
RnRMarketResearch.com adds “Pulmonary Embolism – Pipeline Review, H1 2015” to its store.
NEW YORK, April 21, 2015 /PRNewswire/ -- The New York City law firm of Rheingold, Valet, Rheingold, McCartney & Giuffra LLP this week commenced two wrongful death lawsuits, each involving
Legal-Bay, Lawsuit Money Advance Firm, says Boehringer submitted a supplemental new drug application to the FDA for Pradaxa so it can be used to treat the prophylaxis of deep venous thrombosis (DVT)
The San Diego based law firm with its national network of experienced lawyers comments on the FDA's Adverse Reaction changes to the anticoagulant's labeling, as well as the development
While the surveyed physicians were pleased that new blood thinning options such as Xarelto are now available, there was concern about the lack of an antidote to reverse internal bleeding, a side
The report’s publication comes as dozens of people pursue Xarelto lawsuits for internal bleeding and other serious complications allegedly related to its use. New
- A young chicken: also used as a pet name for children.